NRAS and chronic myelogenous leukemia, BCR-ABL1 positive: We found that expression of NRAS p.(Gln61Lys) promotes survival of CML cells under TKI exposure by reduction of apoptosis and increased cell viability, showing that this mutation is likely the main cause of resistance of our nilotinib-resistant subline N-R2.